Today's Highlights
Premium
Prohost Outperforming Firms. What About ACHN?
Biogen Idec (BIIB) : The FDA approved Biogen Idec drug Plegridy -- a long-acting multiple sclerosis drug expected to replace its older big-selling Avonex treatment. The drug is intended to reduce rela...
P
Prohost Biotech
1 min read
17
0
Unlock Premium Content
This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.
Unlimited articles
Expert analysis
Research reports
Comments (0)
Please sign in to join the discussion